Legend Biotech Corp (LEGN) — Working Capital to Net Assets Ratio
Legend Biotech Corp (LEGN) has a Working Capital to Net Assets ratio of 59.3% as of March 2026. Working capital of $573.62 Million (current assets of $1.08 Billion minus current liabilities of $509.12 Million) is measured against net assets of $967.73 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Legend Biotech Corp free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Legend Biotech Corp Working Capital to Net Assets (2017–2025)
This chart shows how Legend Biotech Corp's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 59.3%, reflecting working capital of $573.62 Million against net assets of $967.73 Million USD. See Legend Biotech Corp (LEGN) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Legend Biotech Corp (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Legend Biotech Corp from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Legend Biotech Corp market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 60.9% | $610.70 Million | $1.00 Billion | $1.25 Billion | $636.40 Million | ▼ -35.8 pp |
| 2024 | 96.7% | $1.01 Billion | $1.04 Billion | $1.28 Billion | $277.64 Million | ▼ -5.7 pp |
| 2023 | 102.4% | $1.28 Billion | $1.25 Billion | $1.50 Billion | $216.42 Million | ▼ -5.3 pp |
| 2022 | 107.7% | $801.33 Million | $744.31 Million | $1.10 Billion | $297.79 Million | ▲ +13.6 pp |
| 2021 | 94.1% | $720.65 Million | $765.94 Million | $949.85 Million | $229.20 Million | ▲ +14.3 pp |
| 2020 | 79.8% | $478.38 Million | $599.82 Million | $593.94 Million | $115.57 Million | ▲ +144.3 pp |
| 2019 | -64.6% | $79.34 Million | $-122.87 Million | $207.10 Million | $127.76 Million | ▼ -2004.3 pp |
| 2018 | 1939.8% | $167.77 Million | $8.65 Million | $326.96 Million | $159.19 Million | ▲ +470.3 pp |
| 2017 | 1469.5% | $178.78 Million | $12.17 Million | $230.90 Million | $52.12 Million | — |